GHK-Cu (Copper Peptide) dosing & administration

Pickart L · 2008

This comprehensive review showed GHK-Cu activates a wide range of tissue repair processes—attracting repair cells, boosting collagen and elastin, increasing blood vessel growth factors (VEGF), and stimulating hair follicle enlargement. In studies on aged skin, it tightened loose skin and improved elasticity.

Pickart L, Margolina A · 2018

Gene analysis revealed GHK-Cu influences over 4,000 human genes—about 6% of the entire genome. It upregulates collagen, elastin, and tissue repair genes while suppressing inflammation and promoting DNA repair. It's one of the most broadly-acting regenerative peptides known.

Pickart L, Vasquez-Soltero JM, Margolina A · 2014

GHK was found to reset gene expression patterns of diseased cells (including cancer and COPD cells) back toward healthier states. It increased cellular 'stemness' and activated multiple repair pathways simultaneously—suggesting it works as a broad biological reset signal.

Canapp SO, Farese JP, Schultz GS, Gowda S, et al. · 2003

Topical GHK-Cu dramatically accelerated wound healing—wounds shrank by 64.5% in the treatment group versus only 28.2% in controls by day 13. It also significantly reduced inflammatory markers TNF-alpha and destructive enzymes MMP-2/MMP-9.

Choi HR, Kang YA, Ryoo SJ, Shin JW, et al. · 2012

GHK increased the number of stem cells in skin tissue and boosted their ability to multiply. It worked by increasing integrin expression—the 'anchor proteins' that keep stem cells in their regenerative niche. This explains part of how GHK-Cu rejuvenates aging skin.

Simeon A, Monier F, Emonard H, Gillery P, et al. · 1999

GHK-Cu was shown to intelligently regulate wound remodeling enzymes (MMPs)—increasing them when needed for tissue restructuring and decreasing them to prevent excessive breakdown. This 'smart regulation' helps explain why GHK-Cu improves scar quality.

Miller TR, Wagner JD, Baack BR, Eisbach KJ · 2006

A randomized human trial of topical GHK-Cu, and the only controlled human trial of it indexed in PubMed. Thirteen patients who had circumoral CO2 laser resurfacing were randomized to an aftercare regimen with or without GHK-Cu. Blinded evaluators and computer analysis found no significant difference between the groups in how fast redness resolved, and no significant improvement in wrinkles or overall skin quality. Everyone improved; the GHK-Cu group did not improve more. The one measure that did separate was the patients' own rating of overall skin quality (P = 0.04).

Pickart L, Vasquez-Soltero JM, Margolina A · 2015

This review documents that GHK is present in human plasma, saliva, and urine, and that plasma levels fall from about 200 ng/mL at age 20 to about 80 ng/mL by age 60. It reports GHK's copper binding constant as log10 = 16.44, with the copper(II) ion coordinated by the histidine imidazole nitrogen, the alpha-amino nitrogen of glycine, and a deprotonated amide nitrogen. It also summarizes animal studies in which GHK injected at a site distant from the wound, or injected intraperitoneally, produced wound healing throughout the body.

Deng M, Zhang Q, Yan L, Bian Y, et al. · 2023

In mice with smoke-induced muscle damage, GHK-Cu given by intraperitoneal injection (0.2 or 2 mg/kg weekly for 7 weeks) reduced muscle loss and improved grip strength, showing that injected GHK-Cu reaches and acts on tissue away from the injection site. In people with COPD, plasma GHK was lower than in age-matched healthy subjects (70.3 vs 133.0 ng/mL).

Pickart L, Vasquez-Soltero JM, Margolina A · 2012

This review describes GHK as acting by delivering copper into the cell in a form that is non-toxic and usable by the cell, rather than as free copper ion. It also reports GHK's copper binding constant (log10 = 16.44) and the coordination of copper by the histidine imidazole nitrogen.

Borkow G · 2014

This review sets out the copper-dependent enzymes of skin: copper is a cofactor of superoxide dismutase (antioxidant defense), of lysyl oxidase (needed for cross-linking of extracellular matrix proteins such as collagen and elastin), and of tyrosinase (melanin synthesis). It notes that Cu-GHK, found in human serum, binds copper strongly and increases collagen and elastin synthesis.

Gruchlik A, Chodurek E, Dzierzewicz Z · 2014

In cultured normal human dermal fibroblasts, 1 nM GHK and 1 nM GHK-Cu both lowered the IGF-2-driven increase in TGF-beta1 secretion measured by ELISA. The authors note TGF-beta1's role in scar tissue formation and suggest the peptide may be useful in treating and preventing hypertrophic scars.

ClinicalTrials.gov registry record · 2026

The only interventional GHK-Cu trial currently registered on ClinicalTrials.gov, and it is topical: a Phase 2 study of a GHK-Cu gel applied to acute skin wounds, listed as recruiting. Searching the registry for "GHK-Cu" or "copper tripeptide" returns this study and one transdermal patch study; no registered trial gives GHK-Cu by injection.

Mateescu DM, Gavrilescu DM, Mincioaga RI, Pah AM, et al. · 2026

Systematic evidence-mapping review (Pharmaceutics 2026; full text PMC13610439). Its comparison table describes GHK-Cu as an endogenous tripeptide and the reference entity among copper peptides, with the best-characterized coordination and broadest multimodal dataset, while the synthetic analogue AHK-Cu carries cosmetic hair and skin claims on a thin, poorly characterized evidence base. The review also states that human clinical evidence for GHK-Cu remains sparse (a 13-participant post-CO2-laser study was negative on objective endpoints), that no validated GHK-Cu-specific human NOAEL or labile-copper safety threshold exists, that dietary copper limits (EFSA 5 mg/day; US upper limit 10 mg/day) cannot be converted directly into parenteral limits, and that the Cu(II) complex has a visible d-d absorption band at 580-600 nm used to confirm complex formation.

Liu T, Liu Y, Zhao X, Zhang L, et al. · 2024

Formulation study of topical GHK-Cu delivery for hair growth (Bioact Mater 2024; full text PMC10643103). Describes copper peptides (GHK-Cu) as complexes of the GHK tripeptide with divalent copper, and states that copper peptides have a blue color and that the amount of copper peptide can be estimated from the hue of the system.

Najafi N, Maatouk H, Vardanyan KG, Vartanian KB, Agrawal DK · 2026

Systematic review (Arch Intern Med Res 2026; NIH author manuscript PMC13604022). States that GHK-Cu is widely used in post-procedural cosmetic dermatology and that copper tripeptide-containing creams have been part of post-laser, post-Mohs, post-microneedling and post-hair-transplant care regimens for nearly two decades, while the published randomized-trial base for surgical indications is small; the one randomized post-CO2-laser trial found no objective benefit but higher patient satisfaction.